[1]
P. Saelee, R. Chanwat, and T. Pongtheerat, “Association between EGF +61G/A Polymorphisms and Prognosis in Hepatocellular Carcinoma”, Bu J Med, vol. 8, no. 1, pp. 17–27, Jul. 2021.